Toxicity and potency evaluation of pertussis vaccines (Q35648263)

9 August 2017

1 reference

title

Toxicity and potency evaluation of pertussis vaccines (English)

1 reference

9 August 2017

Michael J Corbel

1

1 reference

9 August 2017

Dorothy K L Xing

series ordinal

2

1 reference

9 August 2017

publication date

1 February 2004

1 reference

Expert Review of Vaccines

9 August 2017

published in

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

89-101

1 reference

Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

The modified leukocytosis promoting factor (LPF)-test: A valuable supplement to the mouse weight gain (MWG)-test in toxicity control of whole cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

The effects of purified components of Bordetella pertussis in the weight gain test for the toxicity testing of pertussis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Calmodulin activates prokaryotic adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of FHA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Integrins: a family of cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Serum resistance inbvg-regulated mutants ofBordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Morbidity of pertussis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

A Placebo-Controlled Trial of a Pertussis-Toxoid Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Fimbrial typing of Bordetello pertussis isolates: agglutination with polyclonal and monoclonal antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Toxin inactivation and antigen stabilization: two different uses of formaldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Detection of residual pertussis toxin in vaccines using a modified ribosylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Evaluation of endotoxin content of diphtheria?tetanus-acellular pertussis combined (DTaP) vaccines that interfere with the bacterial endotoxin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Muramyl peptide probes derived from tracheal cytotoxin of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

Stereotyped and specific gene expression programs in human innate immune responses to bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.3.1.89

21 January 2018

Identifiers

DOI

10.1586/14760584.3.1.89

1 reference

9 August 2017

1 reference